Biogen Pharmachem Industries Ltd — Important, 23-03-2026: Company Update

Biogen Pharmachem's Board has approved several key proposals, pending shareholder approval. The company intends to increase its Authorized Share Capital from 91 Cr to 108 Cr. A significant move is the proposed issuance of bonus shares in a 1:6 ratio, meaning one new share for every six held. This will involve issuing approximately 15.04 Cr new shares, increasing the paid-up capital from 90.26 Cr to 105.30 Cr, funded by 15.04 Cr from the Securities Premium. Additionally, the Board sanctioned the appointment of M/s. Goenka Mehta & Associates as new Statutory Auditors. These actions aim to strengthen the company's capital structure and governance.